Skillman, NJ, United States of America

Matthew Machado

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Kenvue Brands LLC. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew Machado: Innovator in Allergy Mitigation

Introduction

Matthew Machado is an accomplished inventor based in Skillman, NJ (US). He has made significant contributions to the field of allergy management through his innovative patent. His work focuses on personalized solutions to mitigate allergen symptoms, showcasing his commitment to improving individual health outcomes.

Latest Patents

Matthew holds a patent for a "Method to mitigate allergen symptoms in a personalized and hyperlocal manner." This system and method are designed to determine an individual's allergy impact profile. It predicts how environmental conditions may affect allergy symptoms and recommends appropriate treatments based on the predicted impact. This innovative approach represents a significant advancement in allergy management.

Career Highlights

Matthew is currently employed at Kenvue Brands LLC, where he continues to develop solutions that address health challenges related to allergies. His work at Kenvue allows him to collaborate with other professionals in the field, further enhancing his contributions to allergy research and treatment.

Collaborations

Matthew has worked alongside talented colleagues, including Christina Lee and Russell Gould. Their combined expertise fosters a collaborative environment that drives innovation and enhances the effectiveness of their projects.

Conclusion

In summary, Matthew Machado is a dedicated inventor whose work in allergy mitigation is making a positive impact on individual health. His innovative patent and collaboration with colleagues at Kenvue Brands LLC highlight his commitment to advancing allergy management solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…